A medical product and parenteral formulation are provided. The parenteral formulation is preferably for fluid restricted patients such as pediatric patients and can include amino acids, lipids, carbohydrates and electrolytes. The parenteral formulation can be housed in a multi-chamber container for separately storing a amino acid component, a lipid component and a carbohydrate component to provide a medical product. Frangible barriers preferably peelable seals separate the components and allow for admix to form a just prior to administration. Electrolytes can also be included in one or both of the carbohydrate and amino acid components; preferably the electrolytes are included in the amino acid component and the amino acid component includes cysteine. The multi-chamber container preferably facilitates the selective activation of the peelable seals to permit the admixing of less than all the separately stored components. The medical product can include a parenteral formulation for supplying the mean nutritional requirements for separate patient populations, such as for preterm infants, term to two year olds, and two to eighteen year olds.

 
Web www.patentalert.com

> Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds

~ 00342